Linking Medical Activities to Measurable Patient Outcomes

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “Patient-Focused Impact: Linking Medical Activities to Outcomes”

STUDY OVERVIEW

Demonstrating how Medical activities influence real-world outcomes has become one of the most urgent challenges for Medical Affairs. With organizations under pressure to show tangible impact, leaders need reliable ways to connect field engagement, insight generation, evidence use, and scientific exchange to measurable shifts in patient care.

Best Practices, LLC developed this study to highlight how high-performing companies establish outcomes-focused measurement systems. It explores how Medical teams leverage unified data sets, PROs, RWE, and AI-enabled analytics to track changes in diagnosis patterns, treatment flow, adherence, and quality of care. The research also uncovers the performance metrics that make impact assessment more actionable and less resource-intensive.

Drawing on benchmarks across large, mid-small, connected, and siloed organizations, this study provides Medical Affairs leaders with a clear roadmap to strengthen performance evaluation, build credible impact narratives, and clearly link Medical activities to real-world improvements in patient outcomes.

KEY TOPICS

Metrics for assessing patient-focused impact
Data sources for actionable outcome tracking
Strategic use of PROs and registries

KEY METRICS

Top-ranked metrics for measuring the impact of Medical Affairs activities on patient outcomes
Highly effective data sources for “actionable” tracking of patient outcomes
Effective use of patient-reported outcomes (PROs) to identify new support opportunities
Supporting advocacy-driven registries and data collection – Connected vs. siloed organizations

SAMPLE KEY FINDINGS

Impact metrics: Across benchmark segments, the top-rated metrics for linking medical tactics to improved health outcomes are: 1) Care behavior changes, 2) # diagnosed, and 3) # treated consistently rank as the top metrics for all organization types. Large pharma is also focused on “Guideline concordance levels.”

METHODOLOGY

Best Practices LLC conducted a benchmark survey with 27 Medical Affairs leaders from 21 biopharma companies, supplemented by deep-dive interviews to capture real-world examples and strategic insights.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Consumer Products; Diagnostic; Medical Device; Health Care; Clinical Research; Laboratories

Companies Profiled:
AbbVie; ADVANZ PHARMA; Alnylam Pharmaceuticals; argenx; Arrowhead Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biogen; Boehringer Ingelheim; Cytokinetics; Eva Pharma; Ferring Pharmaceuticals; Gr�nenthal; Insmed; Jazz Pharmaceuticals; Merck; Otsuka; Sanofi; Vertex Pharmaceuticals; Xenon Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Patient-Focused Impact: Linking Medical Activities to Outcomes

ID: 5902

Features:

Pages/Slides: 32

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
622B04869302C696D00258D4F004F2EE3
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-patient-focused-impact-linking-medical-activities-outcomes?opendocument
18
19opendocument
2018.97.9.172
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB